{
  "actions": [
    {
      "acted_at": "2008-07-31",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2008-07-31",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s3409-110",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "110",
  "cosponsors": [
    {
      "bioguide_id": "G000386",
      "district": null,
      "name": "Grassley, Chuck",
      "original_cosponsor": true,
      "sponsored_at": "2008-07-31",
      "state": "IA",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2008-07-31",
  "number": "3409",
  "official_title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Drug and Device Accountability Act of 2008",
  "sponsor": {
    "bioguide_id": "K000105",
    "district": null,
    "name": "Kennedy, Edward M.",
    "state": "MA",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2008-07-31",
  "subjects": [
    "Administrative fees",
    "Clinical trials",
    "Commerce",
    "Communication in medicine",
    "Damages",
    "Data banks",
    "Defective products",
    "Drug adulteration",
    "Drug approvals",
    "Drug industry",
    "Drugs",
    "Economics and Public Finance",
    "Fines (Penalties)",
    "Foreign Trade and International Finance",
    "Government Operations and Politics",
    "Government paperwork",
    "Governmental investigations",
    "Health",
    "Health information systems",
    "Imports",
    "Internet",
    "Labeling",
    "Law",
    "Licenses",
    "Medical technology",
    "Product safety",
    "Science, Technology, Communications",
    "Subpoena",
    "Wage restitution",
    "Whistle blowing"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2008-07-31",
    "date": "2008-12-12T22:27:32Z",
    "text": "Drug and Device Accountability Act of 2008 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to deem a drug or device to be misbranded unless certain conditions related to registration of establishments, identification of prior transactions, labeling for country of manufacture, and provision of required information on importation are met.\n\nIncludes in the definition of \"drug\" a precursor ingredient.\n\nRepeals the registration exemption for manufacturers of harmless inactive ingredients that become components of drugs.\n\nExpands the information required to be included for registration of establishments.\n\nDeems a drug to be adulterated if certain conditions related to verification of identity and purity, identification of establishments, consistency with current manufacturing technologies, and conformity with good distribution and import practices are not met.\n\nSets forth provisions governing importation of a drug.\n\nSets forth required actions, including cessation of distribution, if there is a reasonable probability that a drug intended for human use would cause serious, adverse health consequences or death.\n\nEstablishes actions manufacturers must take regarding any defective drug.\n\nSets forth additional required certifications for submissions related to drugs and devices regarding accuracy of information submitted and personal knowledge of such information.\n\nEstablishes whistleblower protection for employees providing information regarding a drug, biological product, or device.\n\nDirects the Secretary of Health and Human Services to establish and maintain a corps of inspectors dedicated to inspections of foreign establishments and foreign facilities.\n\nAuthorizes the Secretary to conduct investigations, subpoena witnesses, and compel attendance of witnesses as necessary to carry out authority under the FFDCA or provisions governing the regulation of biological products.\n\nRequires reports to the Secretary regarding certain civil actions involving a regulated product."
  },
  "titles": [
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Drug and Device Accountability Act of 2008",
      "type": "short"
    },
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Drug and Device Accountability Act of 2008",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2020-02-10T17:02:03Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/110/s/BILLSTATUS-110s3409.xml"
}